Target intelligence / Profile preview

Chromobox homolog 4 (CBX4)

Target
CBX4
Molecular classification
Polycomb group protein, Transcription factor (chromatin regulator), SUMO E3 ligase, Epigenetic modifier
01

Overview

Chromobox homolog 4 (CBX4) is a nuclear protein that belongs to the polycomb group (PcG) family and functions as both a component of the PRC1 complex and as a SUMO E3 ligase[1][2][3][4][5]. Its chromodomain enables specific binding to di- and trimethylated lysines (H3K27me3, H3K9me3) on histone H3, facilitating gene silencing and maintenance of cell identity[2]. In addition, CBX4 contains SUMO-interacting motifs (SIMs) and a conserved Pc box. CBX4 is required for diverse processes including transcriptional silencing, DNA damage repair, cell cycle regulation, and cell proliferation[2][3]. It plays context-dependent roles in cancer, with evidence for both tumor suppressive and oncogenic activities: for example, it suppresses metastasis via HDAC3 recruitment in colorectal carcinoma, while promoting progression and stemness in hepatocellular carcinoma by enhancing HIF-1α sumoylation and VEGF expression[1][5][7]. CBX4 is also implicated in regulating cellular senescence and response to ionizing radiation through sumoylation-mediated DNA damage repair pathways[2][3]. No approved drugs currently target CBX4, though chemical probes (e.g., UNC3866) have been developed for research applications[6]. If further structure-specific or pathway-related information is needed, note that CBX4 functions through the PRC1 complex and its own SUMO E3 ligase activity, both critical for its biological roles[2][3][4][5][7].

Other names
Polycomb 2 homologPc2hPc2hPC2PC2NBP16Chromobox protein homolog 4NS5ATP1-binding protein 16Pc class 2 homolog (Drosophila)Chromobox-like protein 4
02

Mechanism of action

Modulation of gene expression through chromodomain-mediated binding to methylated histone H3 (H3K27me3/H3K9me3). SUMOylation of target proteins, e.g., BMI1, facilitating DNA damage repair. Recruitment of histone deacetylase 3 (HDAC3), leading to histone deacetylation and transcriptional repression (e.g., suppression of Runx2). Regulation of cellular senescence and stemness.

03

Biological functions

Epigenetic gene silencingTranscriptional repressionHistone modification (chromodomain binding H3K27me3 and H3K9me3)Cell cycle regulationDNA damage response (DDR)Cell proliferation controlRegulation of cellular senescence
04

Disease associations

Cancer (hepatocellular carcinoma, gastric cancer, colorectal cancer, lung adenocarcinoma, osteosarcoma)Metastasis (can act as either an oncogene or tumor suppressor depending on cellular context)Osteoarthritis (emerging role in post-traumatic OA)
05

Safety considerations

Oncogenic or tumor suppressor potential depending on cellular context; modulating CBX4 may affect both cancer suppression and progressionPotential challenges in targeting due to dual functions (transcriptional repression via PRC1 and SUMO E3 ligase activity)Impact on cell cycle, DNA repair, and epigenetic gene regulation may carry risks of genomic instability, off-target effects, and impaired normal cell function
06

Interacting drugs

UNC3866, a chemical probe selective for CBX4 chromodomain
07

Biomarkers

CBX4 expression correlates with tumor progression, stemness, angiogenesis (e.g., VEGF upregulation in HCC), and disease outcomeCBX4/Runx2 ratio as a prognostic marker in colorectal cancer

Beyond the preview

Go deeper on Chromobox homolog 4 (CBX4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromobox homolog 4 (CBX4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call